Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes
Journal of Translational Medicine 17:110, 2019
Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development
In: Krentz A., Weyer C., Hompesch M. (eds) Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Springer, Cham. pp 369-403, 2019
Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis
Digestive Diseases and Sciences 64(5):1238-1256, 2019
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis
World Journal of Gastroenterology 24(2):179–194, 2018
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
World Journal of Gastroenterology 24(2):195–210, 2018
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Drug Discovery Today 22(11):1707–1718, 2017
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
World Journal of Hepatology 8(16):673-684, 2016